{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:15:38Z","timestamp":1768569338377,"version":"3.49.0"},"posted":{"date-parts":[[2025,5,31]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":32,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,5,31]]},"abstract":"<jats:title>Summary<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Yellow fever virus (YFV) and West Nile virus (WNV) co-circulate with other arboviruses, including Zika (ZIKV), dengue (DENV), and chikungunya virus (CHIKV), in sub-Saharan Africa. Associations between preexisting YFV and WNV immunity with symptoms and adverse infant outcomes among pregnant women exposed to flaviviruses are unknown.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively studied a prospective cohort of pregnant women enrolled between 2019 and 2022 in Jos, Nigeria. Rapid tests identified ZIKV, DENV, and CHIKV IgM\/IgG reactivity for enrollment; 216 women underwent Western blot for YFV and WNV IgG. Logistic regression evaluated associations between arboviral seropositivity and maternal symptoms or adverse infant outcomes. Sequential serology of mother-infant pairs estimated the persistence of passively transferred maternal YFV antibodies.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>YFV IgG was detected in 50.5% (109\/216) and WNV IgG in 5.1% (11\/216) of maternal samples. YFV and WNV seropositivity was significantly associated with maternal symptoms (OR = 2.02, 95% CI: 1.35\u20133.02, P = 0.001), as was YFV seropositivity alone (OR = 1.77, 95% CI: 1.21\u20132.61, P &lt; 0.004). CHIKV IgM reactivity was significantly associated with abnormal infant outcomes (OR = 2.38, 95% CI: 1.43\u20134.02, p = 0.001), but not ZIKV and DENV IgM reactivity. Passive maternal YFV IgG waned in infants at a median of 3.1 months (IQR: 1.65-5.35 months) after birth.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>YFV and WNV seropositivity was associated with maternal symptoms but not with adverse infant outcomes. Rapid waning of maternal YFV IgG highlights infant vulnerability and supports enhanced surveillance and maternal immunization strategies.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.05.30.25328229","type":"posted-content","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T18:10:22Z","timestamp":1748715022000},"source":"Crossref","is-referenced-by-count":1,"title":["Preexisting Yellow Fever Virus and West Nile Virus Immunity and Pregnancy Outcomes in a Nigerian Cohort with Endemic Flavivirus Exposure"],"prefix":"10.64898","author":[{"given":"Tae-woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby Brooke","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailee Naito-","family":"Keoho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Ogwuche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atiene S.","family":"Sagay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Ajeong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Kung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis J.","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025060402152432000_2025.05.30.25328229v1.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2019.04.009"},{"key":"2025060402152432000_2025.05.30.25328229v1.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05930-7"},{"key":"2025060402152432000_2025.05.30.25328229v1.3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijid.2023.11.036","article-title":"Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria","volume":"139","year":"2024","journal-title":"Int J Infect Dis"},{"key":"2025060402152432000_2025.05.30.25328229v1.4","doi-asserted-by":"publisher","DOI":"10.1002\/bdr2.2134"},{"issue":"2","key":"2025060402152432000_2025.05.30.25328229v1.5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/JS9.0000000000000086","article-title":"Yellow fever virus, a mosquito-borne flavivirus posing high public health concerns and imminent threats to travellers - an update","volume":"109","year":"2023","journal-title":"Int J Surg"},{"key":"2025060402152432000_2025.05.30.25328229v1.6","doi-asserted-by":"crossref","unstructured":"Santini M , Haberle S , \u017didovec-Lepej S , Savi\u0107 V , Kusulja M , Papi\u0107 N , et al. Severe West Nile Virus Neuroinvasive Disease: Clinical Characteristics, Short-and Long-Term Outcomes. Pathogens. 2022;11(1).","DOI":"10.3390\/pathogens11010052"},{"key":"2025060402152432000_2025.05.30.25328229v1.7","doi-asserted-by":"crossref","unstructured":"Howard-Jones AR , Pham D , Sparks R , Maddocks S , Dwyer DE , Kok J , et al. Arthropod-Borne Flaviviruses in Pregnancy. Microorganisms [Internet]. 2023; 11(2).","DOI":"10.3390\/microorganisms11020433"},{"key":"2025060402152432000_2025.05.30.25328229v1.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2024"},{"key":"2025060402152432000_2025.05.30.25328229v1.9","doi-asserted-by":"crossref","unstructured":"Khandia R , Munjal A , Dhama K , Karthik K , Tiwari R , Malik YS , et al. Modulation of Dengue\/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Front Immunol. 2018;9:597.","DOI":"10.3389\/fimmu.2018.00597"},{"key":"2025060402152432000_2025.05.30.25328229v1.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav6618"},{"key":"2025060402152432000_2025.05.30.25328229v1.11","doi-asserted-by":"crossref","unstructured":"Zambrana JV , Hasund CM , Aogo RA , Bos S , Arguello S , Gonzalez K , et al. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Sci Transl Med. 2024;16(749):eadn2199.","DOI":"10.1126\/scitranslmed.adn2199"},{"key":"2025060402152432000_2025.05.30.25328229v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2019.05.002"},{"issue":"1","key":"2025060402152432000_2025.05.30.25328229v1.13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s12879-023-08526-z","article-title":"Bola Oriowo Oyefolu A. Molecular surveillance of arboviruses in Nigeria","volume":"23","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025060402152432000_2025.05.30.25328229v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105616"},{"key":"2025060402152432000_2025.05.30.25328229v1.15","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0264"},{"key":"2025060402152432000_2025.05.30.25328229v1.16","doi-asserted-by":"publisher","DOI":"10.2149\/tmh.2013-13"},{"issue":"3","key":"2025060402152432000_2025.05.30.25328229v1.17","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S2214-109X(23)00556-9","article-title":"Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis","volume":"12","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"11","key":"2025060402152432000_2025.05.30.25328229v1.18","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.vaccine.2020.12.049","article-title":"Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies","volume":"40","year":"2022","journal-title":"Vaccine"},{"issue":"12","key":"2025060402152432000_2025.05.30.25328229v1.19","doi-asserted-by":"crossref","first-page":"e0004262","DOI":"10.1371\/journal.pntd.0004262","article-title":"Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics","volume":"9","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"2025060402152432000_2025.05.30.25328229v1.20","doi-asserted-by":"publisher","DOI":"10.1086\/648407"},{"key":"2025060402152432000_2025.05.30.25328229v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.09.015"},{"key":"2025060402152432000_2025.05.30.25328229v1.22","unstructured":"Organization WH. WHO Child Growth Standards: Length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development Geneva: World Health Organization; 2006 [http:\/\/www.who.int\/childgrowth\/standards\/second_set\/technical_report_2.pdf]"},{"issue":"1","key":"2025060402152432000_2025.05.30.25328229v1.23","doi-asserted-by":"crossref","first-page":"2301666","DOI":"10.1080\/22221751.2023.2301666","article-title":"Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions","volume":"13","year":"2024","journal-title":"Emerging Microbes & Infections"},{"key":"2025060402152432000_2025.05.30.25328229v1.24","doi-asserted-by":"crossref","unstructured":"Niewiesk S . Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014;5:446.","DOI":"10.3389\/fimmu.2014.00446"},{"key":"2025060402152432000_2025.05.30.25328229v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30323-8"},{"key":"2025060402152432000_2025.05.30.25328229v1.26","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06727-y"},{"key":"2025060402152432000_2025.05.30.25328229v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30419-X"},{"issue":"4","key":"2025060402152432000_2025.05.30.25328229v1.28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2017.01.041","article-title":"Sequence, structure and function relationships in flaviviruses as assessed by evolutive aspects of its conserved non-structural protein domains","volume":"492","year":"2017","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2025060402152432000_2025.05.30.25328229v1.29","doi-asserted-by":"crossref","unstructured":"Mateus J , Grifoni A , Voic H , Angelo MA , Phillips E , Mallal S , et al. Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees. Viruses. 2020;12(11).","DOI":"10.3390\/v12111300"},{"key":"2025060402152432000_2025.05.30.25328229v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2007.03.002"},{"key":"2025060402152432000_2025.05.30.25328229v1.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001311"},{"issue":"6","key":"2025060402152432000_2025.05.30.25328229v1.32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/1471-0528.16562","article-title":"Chikungunya infection in pregnancy - reassuring maternal and perinatal outcomes: a retrospective observational study","volume":"128","year":"2021","journal-title":"Bjog"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.05.30.25328229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:37:16Z","timestamp":1768509436000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.05.30.25328229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1101\/2025.05.30.25328229","relation":{},"subject":[],"published":{"date-parts":[[2025,5,31]]},"subtype":"preprint"}}